Clinical Trial Update: Single Dose Study of Phentolamine Mesylate Eye Drops in Patients With Severe Night Vision Disturbances [Phase 2]

View source ↗

Summary

Phase 2 single-dose study of phentolamine mesylate eye drops for severe night vision disturbances has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Night Vision Disturbance
• Vision Loss

Drugs mentioned

• Phentolamine mesylate eye drops (phentolamine mesylate)

Snippet

Sponsor: Ocuphire Pharma, Inc. | Conditions: Decrease in Night Vision, Disturbance; Vision, Loss | Phase 2 | Status: COMPLETED | Results posted: 2024-02-15